NORDITROPIN NORDIFLEX (somatropin) by Novo Nordisk. Approved for recombinant human growth hormone [epc]. First approved in 2000.
Drug data last refreshed 17h ago · AI intelligence enriched 2mo ago
NORDITROPIN NORDIFLEX is a recombinant human growth hormone (somatropin) administered by injection for treatment of growth hormone deficiency and related conditions. It is a biologic therapeutic that replaces or supplements endogenous growth hormone to promote linear growth, metabolic function, and body composition normalization.
Moderate competitive pressure (30/100) with declining exclusivity creates urgency for lifecycle management, retention, and cost-containment strategies within a mid-sized team.
Recombinant Human Growth Hormone
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Phase 3 Clinical Trial Evaluating the Efficacy and Safety of Navepegritide and Lonapegsomatropin in Achondroplasia
A Clinical Study of Long-Term Administration of Inpegsomatropin Injection in Participants With Idiopathic Short Stature Who Have Completed Phase Ⅲ Clinical Trials
The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome (TS) and Short Stature
Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults With Growth Hormone Deficiency
A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin (Somatropin) Delivery and Taken up Into the Blood in Healthy Adults
Worked on NORDITROPIN NORDIFLEX at Novo Nordisk? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Novo Nordisk is hiring 1 role related to this product
Working on NORDITROPIN NORDIFLEX offers career exposure in regulatory strategy, payer relations, and lifecycle management within a mature biologic portfolio at a leading endocrinology company. Roles lean toward compliance, market access, and commercial optimization rather than innovation, appealing to professionals seeking stability and deep therapeutic expertise.
8 open roles linked to this drug